• Home
  • Inside Kyverna
  • Our Pipeline & Expanded Access
  • Our Opportunity
  • News
  • Careers
  • Contact
Kyverna Therapeutics
← Back
Apply for this job
kyverna_logo_inv

Links

  • Home
  • News
  • Inside Kyverna
  • Careers
  • Our Pipeline & Expanded Access
  • Contact
  • Our Opportunity

About

Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna’s pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases.

FOLLOW US ON SOCIAL

©2023 Kyverna Therapeutics, Inc. All rights reserved.
  • Privacy Policy